← Open Payments lookup

NATHAN SANBORN: Open Payments

NPI 1235861022 · SALEM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,235 in 85 payments from 20 companies in 2025. Trend: 2023 $1,149 · 2024 $1,285 · 2025 $1,235

Food & beverage: $1,235
CompanyPaymentsAmount
ABBVIE INC.23$241
Astellas Pharma US Inc9$182
AstraZeneca Pharmaceuticals LP6$160
Aimmune Therapeutics, Inc.15$142
Otsuka America Pharmaceutical, Inc.5$75
Novartis Pharmaceuticals Corporation3$66
Axsome Therapeutics, Inc.4$58
Amgen Inc.3$48
Neurocrine BioSciences, Inc.2$42
Bayer Healthcare Pharmaceuticals Inc.2$34

Products named: Veozah, VRAYLAR, ZENPEP, FARXIGA, REXULTI, LEQVIO, EVENITY, UBRELVY.

Industry payments across UT — which companies pay providers there.